144 related articles for article (PubMed ID: 11931624)
1. Synthesis and in vitro antitumor activity of new deaza analogues of the nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523).
Vaidya CM; Wright JE; Rosowsky A
J Med Chem; 2002 Apr; 45(8):1690-6. PubMed ID: 11931624
[TBL] [Abstract][Full Text] [Related]
2. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
4. Analogues of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine (PT523) with modifications in the side chain, p-aminobenzoyl moiety, or 9,10-bridge: synthesis and in vitro antitumor activity.
Rosowsky A; Wright JE; Vaidya CM; Forsch RA; Bader H
J Med Chem; 2000 Apr; 43(8):1620-34. PubMed ID: 10780919
[TBL] [Abstract][Full Text] [Related]
5. Efficient utilization of the reduced folate carrier in CCRF-CEM human leukemic lymphoblasts by the potent antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L- ornithine (PT523) and its B-ring analogues.
Wright JE; Vaidya CM; Chen Y; Rosowsky A
Biochem Pharmacol; 2000 Jul; 60(1):41-6. PubMed ID: 10807943
[TBL] [Abstract][Full Text] [Related]
6. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of N omega-hemiphthaloyl-alpha,omega- diaminoalkanoic acid analogues of aminopterin and 3',5-dichloroaminopterin.
Rosowsky A; Bader H; Wright JE; Keyomarsi K; Matherly LH
J Med Chem; 1994 Jul; 37(14):2167-74. PubMed ID: 8035423
[TBL] [Abstract][Full Text] [Related]
8. The effect of side-chain, para-aminobenzoyl region, and B-ring modifications on dihydrofolate reductase binding, influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatable antifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L- ornithine.
Rosowsky A; Wright JE; Vaidya CM; Forsch RA
Pharmacol Ther; 2000 Mar; 85(3):191-205. PubMed ID: 10739874
[TBL] [Abstract][Full Text] [Related]
9. PT523 and other aminopterin analogs with a hemiphthaloyl-L-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates.
Rosowsky A
Curr Med Chem; 1999 Apr; 6(4):329-52. PubMed ID: 10101216
[TBL] [Abstract][Full Text] [Related]
10. Further studies on the interaction of nonpolyglutamatable aminopterin analogs with dihydrofolate reductase and the reduced folate carrier as determinants of in vitro antitumor activity.
Wright JE; Yurasek GK; Chen YN; Rosowsky A
Biochem Pharmacol; 2003 May; 65(9):1427-33. PubMed ID: 12732354
[TBL] [Abstract][Full Text] [Related]
11. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
[TBL] [Abstract][Full Text] [Related]
13. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain.
Rosowsky A; Forsch RA; Bader H; Freisheim JH
J Med Chem; 1991 Apr; 34(4):1447-54. PubMed ID: 2016722
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523.
Cody V; Galitsky N; Luft JR; Pangborn W; Rosowsky A; Blakley RL
Biochemistry; 1997 Nov; 36(45):13897-903. PubMed ID: 9374868
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel antifolate, N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523), on growth of H35 rat hepatoma and HEPG2 human hepatoma cells.
Rhee MS; Galivan J; Tyobeka EM; Sherman ML; Rosowsky A
Adv Exp Med Biol; 1993; 338():461-4. PubMed ID: 8304158
[No Abstract] [Full Text] [Related]
17. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and enzymatic activation of N-[N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithiny]-L-phenylalanine, a candidate for antibody-directed enzyme prodrug therapy (ADEPT).
Wright JE; Rosowsky A
Bioorg Med Chem; 2002 Mar; 10(3):493-500. PubMed ID: 11814834
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and X-ray crystal structure of a potent dual inhibitor of thymidylate synthase and dihydrofolate reductase as an antitumor agent.
Gangjee A; Yu J; McGuire JJ; Cody V; Galitsky N; Kisliuk RL; Queener SF
J Med Chem; 2000 Oct; 43(21):3837-51. PubMed ID: 11052789
[TBL] [Abstract][Full Text] [Related]
20. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
